Nektar Therapeutics (NASDAQ:NKTR)

Top Analyst Upgrades and Downgrades: Carnival, Facebook, Freeport-McMoRan, Motorola Solutions, Procter & Gamble and Many More

24/7 Wall St. reviews dozens of analyst research reports each day of the week. The goal is to find new investing and trading ideas for our readers. Some analyst reports ...
Read Full Story »

Monday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed ...
Read Full Story »
approve disapprove

Top Analyst Upgrades and Downgrades: Cognizant Tech, Etsy, GoPro, Illumina, Shake Shack, Travelers and More

Stocks were indicated to open marginally lower after a more or less inline payrolls report from the Labor Department. The Dow was indicated down 21 points and the S&P 500 ...
Read Full Story »
KMI Tanker

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little. While the volume was still ...
Read Full Story »
Money close-up

Nektar Slides on Secondary Offering Pricing

Nektar Therapeutics (NASDAQ: NKTR) has filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. The company plans to price its 13 million shares at $13.50, with ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Stocks were getting pounded on Monday after a rough Friday, on the continuation of oil and a weak Europe, even as China was closed for Chinese New Year. The stock ...
Read Full Story »
uncertainty market evolution

Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks

On the close Friday, the NYSE Arca Biotechnology Index is set for a rebalance. What this means is the index will be rebalanced to reflect reweighting allocations across the stocks ...
Read Full Story »
biotech

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight. The ...
Read Full Story »
uncertainty market evolution

Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks

On the close Friday, the NYSE Arca Biotechnology Index (NYSE: BTK) is set for a rebalance. What this means is the index will be adjusted to reflect equal dollar weight ...
Read Full Story »
Pills

Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates

The specialty pharmaceutical sector is exploding with news of takeovers, exchanges and possible mergers. The biggest is the possible deal between activist hedge fund manager Bill Ackman's Pershing Square, Valeant ...
Read Full Story »
buy sell

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

Typically when any major index does a rebalancing, there is a large amount of buying and selling that takes place as the index resets to the new percentage assignments for ...
Read Full Story »
biotech

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Anybody that has been long the biotechnology sector for the past four years has had outstanding returns. Following four straight years of outperformance against the S&P 500, investor interest in ...
Read Full Story »
Pills

Piper Jaffray Has Four Biotech Stocks to Buy With Huge Potential

One of the advantages of having wide Wall Street coverage is the ability to constantly screen even the smallest tidbits of research that is put out each day. Many times ...
Read Full Story »
170622870

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

The start of 2014 for the small and mid-cap biopharma group has been torrid. Positive exciting catalysts delivering greater-than-expected (or even in-line) results have rapidly pushed selected names higher. The ...
Read Full Story »
153790263

Nektar Pain Drug Sends Shareholders To Rehab

Nektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for pain management and for cancer, and now its investigational drug ...
Read Full Story »